Media Summary: Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the The AML Hub was pleased to speak with Eytan Stein, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What ... Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the
Current And Emerging Treatments For - Detailed Analysis & Overview
Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the The AML Hub was pleased to speak with Eytan Stein, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What ... Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the There is a great unmet need for harmonized, up-to-date clinical practice guidelines for the Enrique Ocio, MD, PhD, Marqués de Valdecilla University Hospital, Santander, Spain, outlines In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of ...
Claire Harrison, MD, FRCP, FRCPath, Guy's & St Thomas' NHS Foundation Trust, London, UK, discusses the Pankit Vachhani, MD, University of Alabama at Birmingham, Birmingham, AL, discusses the biology and Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on Access the disclosures, evaluation, and your CME credit via: ... Dr. Anna Burke discusses Adhelm (aducanumab) and other Presentation lead by Dr. Irena Dujmovic, Department of Neurology at UNC Chapel Hill.
Vera Kiyasova, PhD, Director of Clinical Development, NMD Pharma Evan Bailey, MD, Chief Medical Officer, Applied ... This course examines approved and investigational pharmacologic Presentation lead by Dr. Donna Graves, Atrium Health. Join us for an educational discussion on mucosal melanoma, one of the rarest and most challenging forms of melanoma.
